Further investigation revealed that P2X4R suppression inhibited the BDNF/TrkB/ATF4 signaling pathway, with the effects on GBM cell growth and apoptosis being reversible by ATF4 overexpression, highlighting P2X4R as a critical regulator of GBM progression [92]. The gene discussed is ATF4; the disease is glioblastoma.